3B BlackBio DX announced robust Q1 financial results. Standalone revenue reached Rs 2,035.71 lakhs with a profit after tax of Rs 1,246.04 lakhs. Consolidated revenue was Rs 2,223.46 lakhs with a profit after tax of Rs 1,264.45 lakhs. The company reappointed Mr. Dhirendra Dubey as Chairman and Managing Director, and appointed Mr. Vivek Saihgal as an Independent Director. Other expenses included one-time M&A advisory fees of Rs 84.06 lakhs for the acquisition of Coris Bioconcept SRL, Belgium.
3B BLACKBIO DX's Q4 financial results show a 4.68% YoY revenue increase to ₹230.20 crore, despite a 6.80% EBITDA decline to ₹94.60 crore. Net profit marginally improved by 1.54% to ₹92.40 crore. The company's board has recommended a final dividend of ₹4 per equity share, subject to shareholder approval.